2023 annual financial data
Protagonist Therapeutics 2023 Operating margin
Protagonist Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was -156.09%.
Operating income was -93,652,000 USD and net income was -78,955,000 USD.
Operating cash flow was -70,236,000 USD.
Get free Protagonist Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 60,000,000 USD
- Operating income
- -93,652,000 USD
- Net income
- -78,955,000 USD
- Operating cash flow
- -70,236,000 USD